Linking KATP channel activation to p-AKT/mTORC1/eEF2/BDNF axis unravels Nicorandil's promise in countering acetaminophen-induced hepatic encephalopathy in mice

Authors: Essam, Reham M. ^{a, b}, Mohamed, Yasmin S. ^a, El-Sayed, Sarah S. ^a, Kamel, Nada M. ^{a, ⁎}

Source: In Life Sciences 1 April 2025 366-367

Unlocking milk thistle’s anti-psoriatic potential in mice: Targeting PI3K/AKT/mTOR and KEAP1/NRF2/NF-κB pathways to modulate inflammation and oxidative stress

Authors: Kamel, Nada M., El-Sayed, Sarah S., El-Said, Yasmin A.M., El-Kersh, Dina M., Hashem, Mona M., Mohamed, Sarah S.

Source: In International Immunopharmacology 30 September 2024 139

Potential neuroprotective and autophagy-enhancing effects of alogliptin on lithium/pilocarpine-induced seizures in rats: Targeting the AMPK/SIRT1/Nrf2 axis

Authors: El-Sayed, Sarah S., Ali, Shimaa O., Ibrahim, Weam W.

Source: In Life Sciences 1 September 2024 352

Sulforaphane's role in Redefining autophagic Responses in depression associated with polycystic ovarian syndrome: Unveiling the SIRT1/AMPK/LKB1 pathway connection

Authors: Kamel, Ahmed S., El-Sayed, Sarah S., EL Sayed, Nesrine S.

Source: In European Journal of Pharmacology 15 April 2024 969

New insights into the effects of vinpocetine against neurobehavioral comorbidities in a rat model of temporal lobe epilepsy via the downregulation of the hippocampal PI3K/mTOR signalling pathway.

Authors: El-Sayed, Sarah S.¹ sara.elsayed@pharma.cu.edu.eg, El-Yamany, Mohammed F.¹, Salem, Hesham A.¹, El-Sahar, Ayman E.¹

Source: Journal of Pharmacy & Pharmacology. May2021, Vol. 73 Issue 5, p626-640. 15p.

Subject Terms: *CELLULAR signal transduction, *TEMPORAL lobe epilepsy, *ANIMAL disease models, *COMORBIDITY, *CEREBROVASCULAR disease